Statistics

Total Visits

Views
IL28B-based model for prediction of early response in patients with hepatitis C genotype 1&4 treated with peginterferon alfa 2a plus ribavirin (P plus R). OPTIM study66

Select a period of time:

Number of views in the range

Views
IL28B-based model for prediction of early response in patients with hepatitis C genotype 1&4 treated with peginterferon alfa 2a plus ribavirin (P plus R). OPTIM study5

Views

Views
November 20252
December 20251
January 20260
February 20260
March 20261
April 20261
May 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Ecuador2
Chile1
Colombia1
France1
 

Top cities views

Views
Ambato1
Concepción1
Guayaquil1